Mahadevan KK, Dyevoich AM, Chen Y, Li B, Sugimoto H, Sockwell AM, McAndrews KM, Sthanam LK, Wang H, Shalapour S et al. Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer. Science 2024;384:eadh4567.
McCormack M, Eminowicz G, Gallardo D, Diez P, Farrelly L, Kent C, Hudson E, Panades M, Mathew T, Anand A, et al. Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3trial. Lancet. 2024;404:1525–35.
Sethna Z, Guasp P, Reiche C, Milighetti M, Ceglia N, Patterson E, Lihm J, Payne G, Lyudovyk O, Rojas LA et al. RNA neoantigen vaccines prime long-lived CD8 + T cells in pancreatic cancer. Nature 2025;639:1042-1051.
Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, Felip E, Broderick SR, Brahmer JR, Swanson SJ, et al. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med. 2022;386:1973–85.
Verginadis II, Citrin DE, Ky B, Feigenberg SJ, Georgakilas AG, Hill-Kayser CE, Koumenis C, Maity A, Bradley JD, Lin A. Radiotherapy toxicities: mechanisms, management, and future directions. Lancet. 2025;405:338–52.
Xiong A, Wang L, Chen J, Wu L, Liu B, Yao J, Zhong H, Li J, Cheng Y, Sun Y, et al. Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China. Lancet. 2025;405:839–49.
Mann GB, Skandarajah AR, Zdenkowski N, Hughes J, Park A, Petrie D, Saxby K, Grimmond SM, Murugasu A, Spillane AJ et al. Postoperative radiotherapy omission in selected patients with early breast cancer following preoperative breast MRI (PROSPECT): primary results of a prospective two-arm study. Lancet 2024;403:261–270.
Zhao Y, Ma Y, Leng Q, Zhang Q, Li Y, Ji M, Yang H, Li X, Jia G, Li Z, et al. Engineered cell nanovesicle antagonists for androgen deprivation therapy of melanoma. J Colloid Interface Sci. 2025;691:137468–137468.
Gong L, Qi Y, Zhang F, Sun Y, Wang X, Gao W. Thermo-pH-Sensitive Polypeptides Boost Protein Drug’s Tumor Permeation and Pharmacology. Small 2025;21:2501787.
Levy A, Massard C, Michiels S, Deutsch E. Innovative, early-phase clinical trials of drug-radiotherapy combinations. Lancet Oncol. 2025;26:e190–202.
Beik J, Khateri M, Khosravi Z, Kamrava SK, Kooranifar S, Ghaznavi H, Shakeri-Zadeh A. Gold nanoparticles in combinatorial cancer therapy strategies. Coord Chem Rev. 2019;387:299–324.
Huang X, Kuerban K, Fan J, Pan D, Chen H, Liu J, Wang S, Ju D, Zhu YZ, Liu J, Ye L. IL-2-loaded liposomes modified with sorafenib derivative exert a synergistic anti-melanoma effect via improving tumor immune microenvironment and enhancing antiangiogenic activity. Asian J Pharm Sci 2025;20:101020.
Sun S, Wu R, Ma SS, Cao Z, Luo L, Sun S, Cui L, Liang X. Stable liposomal cerasome for ultrasound/H2O2-activated CO release to augment tumor chemotherapy and immunotherapy. Chem Eng J. 2025;510:161398.
Ghosh B, Biswas S. Polymeric micelles in cancer therapy: state of the Art. J Controlled Release. 2021;332:127–47.
Schneider P, Zhang H, Simic L, Dai Z, Schroers B, Akilli-Oeztuerk O, Lin J, Durak F, Schunke J, Bolduan V et al. Multicompartment polyion complex micelles based on triblock polypept(o)ides mediate efficient siRNA delivery to cancer-associated fibroblasts for antistromal therapy of hepatocellular carcinoma. Adv Mater. 2024;36:2404784.
Chen J, Xu X, Wang K, Xue M, Wang Q, Zhong W, Wan Y, Liu X, Zheng J, Gao G, Wang G. Hypoxia-activated liposomes enable synergistic photodynamic therapy for oral cancer. Adv Healthc Mater. 2025;14:2404395.
Zhou Y, Wei R, Wang L, Li J, Wang W, Jiang G, Tan S, Li F, Wang X, Ma X, Xi L. Tumor targeting peptide TMTP1 modified Antigen capture Nano-vaccine combined with chemotherapy and PD-L1 blockade effectively inhibits growth of ovarian cancer. J Nanobiotechnol. 2024;22:483.
Liu Y, Wang X, Wang B, Lu Z, Wu C, He Z, Jiang L, Wei P, Yi T. Constructing activatable photosensitizers using covalently modified mesoporous silica. Adv Sci. 2025;12:2406887.
Cai M, Fu T, Zhu R, Hu P, Kong J, Liao S, Du Y, Zhang Y, Qu C, Dong X, et al. An iron-based metal-organic framework nanoplatform for enhanced ferroptosis and Oridonin delivery as a comprehensive antitumor strategy. Acta Pharm Sinica B. 2024;14:4073–86.
Khulood MT, Jijith US, Naseef PP, Kallungal SM, Geetha VS, Pramod K. Advances in metal-organic framework-based drug delivery systems. Int J Pharm. 2025;673:1-26.
Kang M-J, Cho Y-W, Kim T-H. Metal- and covalent-organic framework-based drug delivery systems: Applications to control cell functions. Coord Chem Rev. 2025;527:216400.
Jiang Z, Wang T, Yuan S, Wang M, Qi W, Su R, He Z. A tumor-sensitive biological metal-organic complex for drug delivery and cancer therapy. J Mater Chem B. 2020;8:7189–96.
Wang C, Liu D, Lin W. Metal-organic frameworks as a tunable platform for designing functional molecular materials. J Am Chem Soc. 2013;135:13222–34.
Singh G, Komal, Radha A, Kaur H, Rani B, Gill BS, Baliyan D, Kaur A, Mohan B. Formulation of naphthol-derived 1,2,3-triazole: A ‘turn-on’ chemosensor for Zr(IV) with anti-cancer and anti-bacterial activities. J Inorg Biochem. 2025;270:112944–112944.
Singh G, Stanzin J, Devi A, Sharma S, Sharma D, Mithun, Gill BS, Vikas, Mohan B. Bis-Schiff base for selective detection of Al(III) and citric acid: Real sample analysis, anticancer potential and docking study. Inorg Chim Acta. 2024;569:122148.
Pang Y, Zhao F, Wang Y, Song Q, Wang Q, Li J, Zhang R, Sun Y. Beyond chemotherapy: Spatiotemporal activation of metal complexes for deep-tissues precision medicine. Coord Chem Rev. 2025;535:216664.
Bakhshi A, Roshan M, Asgari MS, Bijari F, Maleki A. Molecularly imprinted polymers in zeolitic imidazolate frameworks: A comprehensive review. Coord Chem Rev. 2025;534:216561.
Attar GS, Bhalla V, Kumar M. Nanoscale metal-organic frameworks: An emerging versatile tool for next-generation photodynamic therapy. Chemistry-an Asian J. 2025;20:e202500079.
Mohan B, Modi K, Singh G, Paul A, Garazade IM, Pombeiro AJL, Liu X, Sun W, Kim SS. Understanding the electrochemical MOF sensors in detecting cancer with special emphasis on breast carcinoma biomarkers. Top Curr Chem. 2025;383:9.
Mohan B, Dhiman D, Virender, Mehak P, Sun Q, Jan M, Singh G, Raghav N. Metal-organic frameworks (MOFs) structural properties and electrochemical detection capability for cancer biomarkers. Microchem J. 2023;193:108956.
Grancha T, Carne-Sanchez A, Zarekarizi F, Hernandez-Lopez L, Albalad J, Khobotov A, Guillerm V, Morsali A, Juanhuix J, Gandara F, et al. Synthesis of polycarboxylate rhodium(II) metal-organic polyhedra (MOPs) and their use as Building blocks for highly connected metal-organic frameworks (MOFs). Angewandte Chemie-International Ed. 2021;60:5729–33.
Joharian M, Morsali A. Ultrasound-assisted synthesis of two new fluorinated metal-organic frameworks (F-MOFs) with the high surface area to improve the catalytic activity. J Solid State Chem. 2019;270:135–46.
Mohan B, Kumar S, Kumar V, Jiao T, Sharma HK, Chen Q. Electrochemiluminescence metal-organic frameworks biosensing materials for detecting cancer biomarkers. Trac-Trends Anal Chem. 2022;157:116735.
Xu Y, Liu S-Y, Zeng L, Ma H, Zhang Y, Yang H, Liu Y, Fang S, Zhao J, Xu Y et al. An enzyme-engineered nonporous copper(I) coordination polymer nanoplatform for cuproptosis-based synergistic cancer therapy. Adv Mater. 2022;34:2204733.
Xu Z, Yu J, Zhang Y, Wang Y, Li W, Zhang B, Cui W, Li Y, Wang Y, Yang Z et al. In situ oxidation-responsive nanovaccine coordinates photosensitizer and STING agonist for cancer photo-immunotherapy. Nano Today 2025;62:102726.
Ye Z, Yan B, Li H, Tang Q, Yuan K, Hou J, Xu L, Yuan J, Wang S, Jiao W et al. Dual-responsive magnetic vortex nanorings co-deliver lenvatinib and localized heat for synergistic activation of antitumor immunity. Acta Biomater. 2025;198:389–400.
Afruzi FH, Abdouss M, Zare EN, Ghomi ER, Mahmoudi S, Neisiany RE. Metal-organic framework-hydrogel composites as emerging platforms for enhanced wound healing applications: Material design, therapeutic strategies, and future prospects. Coord Chem Rev. 2025;524:216330.
Wang M, Zhang H, Yan S, Zhou Y, Guo X, An D, Zhong W, Zhang Y. Fabrication of MOF-based Nanozyme sensor arrays and their application in disease diagnosis. Coord Chem Rev. 2025;532:216506.
Zhang H, Wei Z, Wang Y, Bi Z, Han W, Shi M, Chen T, Sun Y, Wang L, Zhang S. Au3+-functionalized metal-organic framework coordinated nanotherapeutics for substrate self-supplied parallel catalytic and calcium-overload-mediated therapy of cancer. ACS Appl Bio Mater. 2025;8:446–56.
Zhang D, Wang T, Zhang X, Xu Y, Ming J, Wang X, Liu Z, Li J, Su X. Synchronously delivering melittin and evoking ferroptosis via tumor microenvironment-triggered self-destructive metal-organic frameworks to boost cancer immunotherapy. Adv Healthc Mater. 2025;14:2500003.
Meng J, Bao W, Liu M, Ma Z, Tian Z. MOFs-based nanoagents enable sequential damage to cancer-associated fibroblast and tumor cells for phototriggered tumor microenvironment regulation. Small 2023;20:2470008.
Qian Y, Wang C, Xu R, Wang J, Chen Q, Zhu Z, Hu Q, Shen Q, Shen J-W. Copper-based metal-organic frameworks for antitumor application. J Nanobiotechnol. 2025;23:135.
Wang Z, Han M, Wang Y, Wang N, Yang Y, Shao B, Miao Q, Shi Z, Yan F, Feng S. UiO-66 MOFs-Based epi-nano-sonosensitizer for ultrasound-driven cascade immunotherapy against B-cell lymphoma. ACS Nano. 2025;19:6282–98.
Zhu Z-H, Zhang L, Jia S, Ni Z, Li Y-L, Zou H-H, Yang Y, Hu Y, Ding D, Tang BZ, Feng G. Nanoscale metal-organic framework leveraging water, oxygen, and hydron peroxide to generate reactive oxygen species for cancer therapy. Adv Funct Mater. 2025;35:2419548.
Yalamandala BN, Moorthy T, Liu Z-H, Huynh TMH, Iao HM, Pan W-C, Wang K-L, Chiang C-S, Chiang W-H, Liao L-D et al. A self-cascading catalytic therapy and antigen capture scaffold-mediated T cells augments for postoperative brain immunotherapy. Small 2025;21:2406178.
Guo Z, Xiao Y, Wu W, Zhe M, Yu P, Shakya S, Li Z, Xing F. Metal-organic framework-based smart stimuli-responsive drug delivery systems for cancer therapy: advances, challenges, and future perspectives. J Nanobiotechnol. 2025;23:157.
Zhu X, He C, Tan L, Qi X, Niu M, Meng X, Zhong H. An Fe-Cu bimetallic organic framework as a microwave sensitizer for treating tumors using combined microwave thermotherapy and chemodynamic therapy. J Pharm Anal. 2024;14:100952.
Zhang T, Zhu J, Wu Y, Xia D, Xie X, Li L, Wang Z, Cai K, Zhang J. Structural engineering of sonosensitive nanohybrids by active vanadium species toward collapse of multi-antioxidant defenses and boosted therapy of triple-negative breast cancer. Small Struct. 2025;6:1-14.
Dong J, Ding J, Luo S, Li R, Wang Y, Xiao B, Pei Y, Chen X, Sun W, Pei Z. Remodeling tumor microenvironment using prodrug nMOFs for synergistic cancer therapy. J Nanobiotechnol. 2025;23:123.
Meier JD, Oliver DA, Varvares MA. Surgical margin determination in head and neck oncology: current clinical practice. The results of an international American head and neck society member survey. Head Neck-Journal Sci Specialties Head Neck. 2005;27:952–8.
Moeller BJ, Richardson RA, Dewhirst MW. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev. 2007;26:241–8.
Aller SG. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Biophys J. 2010;98:A755–755.
Miao L, Guo S, Lin CM, Liu Q, Huang L. Nanoformulations for combination or cascade anticancer therapy. Adv Drug Deliv Rev. 2017;115:3–22.
Hu Q, Sun W, Wang C, Gu Z. Recent advances of cocktail chemotherapy by combination drug delivery systems. Adv Drug Deliv Rev. 2016;98:19–34.
Zhang C, An T, Wang D, Wan G, Zhang M, Wang H, Zhang S, Li R, Yang X, Wang Y. Stepwise pH-responsive nanoparticles containing charge-reversible pullulan-based shells and poly(β-amino ester)/poly(lactic-co-glycolic acid) cores as carriers of anticancer drugs for combination therapy on hepatocellular carcinoma. J Controlled Release. 2016;226:193–204.
Abramson JS, Ku M, Hertzberg M, Huang H-Q, Fox CP, Zhang H, Yoon DH, Kim W-S, Abdulhaq H, Townsend W, et al. Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial. Lancet. 2024;404:1940–54.
Wu H, Jin H, Wang C, Zhang Z, Ruan H, Sun L, Yang C, Li Y, Qin W, Wang C. Synergistic cisplatin/doxorubicin combination chemotherapy for multidrug-resistant cancer via polymeric nanogels targeting delivery. ACS Appl Mater Interfaces. 2017;9:9426–36.
Zhang H, Jiang W, Liu R, Zhang J, Zhang D, Li Z, Luan Y. Rational design of metal organic framework nanocarrier-Based codelivery system of doxorubicin hydrochloride/verapamil hydrochloride for overcoming multidrug resistance with efficient targeted cancer therapy. ACS Appl Mater Interfaces. 2017;9:19687–97.
Zhang F-M, Dong H, Zhang X, Sun X-J, Liu M, Yang D-D, Liu X, Wei J-Z. Postsynthetic modification of ZIF-90 for potential targeted codelivery of two anticancer drugs. ACS Appl Mater Interfaces. 2017;9:27332–7.
Kazemi A, Afshari MH, Baesmat H, Keshavarz S, Zeinali F, Zahiri S, Torabi E, Manteghi F, Rohani S. Room-temperature synthesis of pH-responsive MOF nanocarriers for targeted drug delivery in cancer therapy. J Polym Environ. 2025;33:1505–16.
Zhao R-n, Zhu B-w, Xu Y, Yu S-f, Wang W-j. Liu D-h, Hu J-n: Cyclodextrin-based metal-organic framework materials: Classifications, synthesis strategies and applications in variegated delivery systems. Carbohydr Polym. 2023;319:121198.
Kuang Y, Zhang Z, Zhu K, Sun Y, Wang K, Yuan C, Lu J, Luo Y, Liu X, Wan J. Porphyrin-based-MOF nanocomposite hydrogels for synergistic sonodynamic and gas therapy against tumor. Int J Biol Macromol. 2024;280:136086.
Du J, Jia T, Li F, Li Y, Wang Q, He L, Agren H, Chen G. MOF-coated upconversion nanoparticle agents enable synergistic photodynamic therapy and immunotherapy. Adv Funct Mater. 2024;34:2401272.
Tan G, Zhong Y, Yang L, Jiang Y, Liu J, Ren F. A multifunctional MOF-based nanohybrid as injectable implant platform for drug synergistic oral cancer therapy. Chem Eng J. 2020;390:124446.
Hu L, Xiong C, Wei G, Yu Y, Li S, Xiong X, Zou J-J, Tian J. Stimuli-responsive charge-reversal mof@polymer hybrid nanocomposites for enhanced co-delivery of chemotherapeutics towards combination therapy of multidrug-resistant cancer. J Colloid Interface Sci. 2022;608:1882–93.
Duman FD, Monaco A, Foulkes R, Becer CR, Forgan RS. Glycopolymer-functionalized MOF-808 nanoparticles as a cancer-targeted dual drug delivery system for carboplatin and floxuridine. Acs Appl Nano Mater. 2022;5:13862–13873.
Al-Kali A, Tibes R, Atherton P, Palmer J, Alkhateeb HBB, Patnaik M, Begna K, Gangat N, Hashmi S, He R, Litzow M. A phase II study of combination daunorubicin, cytarabine (Ara-c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression. Am J Hematol. 2023;98:472–80.
Liu J, Guo Z, Kordanovski M, Kaltbeitzel J, Zhang H, Cao Z, Gu Z, Wich PR, Lord M, Liang K. Metal-organic frameworks as protective matrices for peptide therapeutics. J Colloid Interface Sci. 2020;576:356–63.
Sahu KP, Singh S, Singh AK, Azad UP, Yadav D, Kumar V, Singh SK. Nanomaterials via ZIF-8: Preparations, catalytic and drug delivery applications. Chem Eng J. 2025;508:160663.
Nie Y, Li D, Peng Y, Wang S, Hu S, Liu M, Ding J, Zhou W. Metal organic framework coated MnO2 nanosheets delivering doxorubicin and self -activated DNAzyme for chemo-gene combinatorial treatment of cancer. Int J Pharm. 2020;585:119513.
Raju P, Balakrishnan K, Mishra M, Ramasamy T, Natarajan S. Fabrication of pH responsive FU@Eu-MOF nanoscale metal organic frameworks for lung cancer therapy. J Drug Deliv Sci Technol. 2022;70:103223.
Mu J, Du Y, Li X, Yan R, Zhong H, Cai M, Yu N, Zhang J, Yuan X, Hua X, Guo S. Collagen-anchored cascade nanoreactors with prolonged intratumoral retention for combined cancer starvation and chemotherapy. Chem Eng J. 2023;451:138554.
Liu X, Gao P, Shi M, Chen Y, Pan W, Li N, Tang B. An autophagy-inhibitory MOF nanoreactor for tumor-targeted synergistic therapy. Biomaterials Sci. 2022;10:3088–91.
Huang C, Tan W, Zheng J, Zhu C, Huo J, Yang R. Azoreductase-responsive metal-organic framework-based nanodrug for enhanced cancer therapy via breaking hypoxia-induced chemoresistance. ACS Appl Mater Interfaces. 2019;11:25740–9.
Yan S, Zeng X, Wang Y, Liu B-F. Biomineralization of bacteria by a metal-organic framework for therapeutic delivery. Adv Healthc Mater. 2020;9:2000046.
Zhao Q, Gong Z, Li Z, Wang J, Zhang J, Zhao Z, Zhang P, Zheng S, Miron RJ, Yuan Q, Zhang Y. Target reprogramming lysosomes of CD8 + T cells by a mineralized metal-organic framework for cancer immunotherapy. Adv Mater. 2021;33:2100616.
Abucafy MP, Galvao Frem RC, Polinario G, Pavan FR, Zhao H, Mielcarek A, Boissiere C, Serre C, Chiavacci LA. MIL-100(Fe) sub-micrometric capsules as a dual drug delivery system. Int J Mol Sci. 2022;23:7670.
Agrawal S, Singh GK, Tiwari S. Focused starvation of tumor cells using glucose oxidase: A comprehensive review. Int J Biol Macromol. 2024;281:136444.
Song K, Ming J, Tao B, Zhao F, Huang S, Wu W, Jiang C, Li X. Emerging glucose oxidase-delivering nanomedicines for enhanced tumor therapy. J Controlled Release 2025;381:S0168-3659.
Zhang J, Zhang J, Yang C. Autophagy in brain tumors: molecular mechanisms, challenges, and therapeutic opportunities. J Translational Med. 2025;23:52.
Ke R, Zhen X, Wang H-S, Li L, Wang H, Wang S, Xie X. Surface functionalized biomimetic bioreactors enable the targeted starvation-chemotherapy to glioma. J Colloid Interface Sci. 2022;609:307–19.
Liu G, Wang L, Liu J, Lu L, Mo D, Li K, Yang X, Zeng R, Zhang J, Liu P, Cai K. Engineering of a core-shell nanoplatform to overcome multidrug resistance via ATP deprivation. Adv Healthc Mater. 2020;9:2000432.
Zhang L, Wang Z, Zhang Y, Cao F, Dong K, Ren J, Qu X. Erythrocyte membrane cloaked metal-organic framework nanoparticle as biomimetic nanoreactor for starvation-activated colon cancer therapy. ACS Nano. 2018;12:10201–11.
Shao F, Wu Y, Tian Z, Liu S. Biomimetic nanoreactor for targeted cancer starvation therapy and cascade amplificated chemotherapy. Biomaterials 2021;274:120869.
Yu J, Wei Z, Li Q, Wan F, Chao Z, Zhang X, Lin L, Meng H, Tian L. Advanced cancer starvation therapy by simultaneous deprivation of lactate and glucose using a MOF nanoplatform. Adv Sci. 2021;8:2101467.
Wang F, Yang J, Li Y, Zhuang Q, Gu J. Efficient enzyme-activated therapy based on the different locations of protein and prodrug in nanomofs. J Mater Chem B. 2020;8:6139–47.
He C, Lu K, Liu D, Lin W. Nanoscale metal-organic frameworks for the co-delivery of cisplatin and pooled SiRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cells. J Am Chem Soc. 2014;136:5181–4.
Teplensky MH, Fantham M, Poudel C, Hockings C, Lu M, Guna A, Aragones-Anglada M, Moghadam PZ, Li P, Farha OK, et al. A highly porous metal-organic framework system to deliver payloads for gene knockdown. Chem. 2019;5:2926–41.
Yang L, Lin Y, Zhang J, Huang J, Qin A, Miao Y, Wang P, Yu X, Wang L, Zhang L. Biomimetic metal-organic frameworks navigated biological bombs for efficient lung cancer therapy. J Colloid Interface Sci. 2022;625:532–43.
Xiao Y, He Y, Zhong D, Liu B, Tang Z, Lan X, Dong Y, Du H, Liu Y, Luo J. Effect of engineered cyanobacterial capsules on a neurogenic bladder after spinal cord injury. ACS Nano. 2025;19:11841–60.
Qiao Y, Luo M, Wang Y, Qi H, Wang M, Pei Y, Sun M, Zhang Z, Huang J, Gong P, et al. Development of a bacteria-nanosapper for the active delivery of ZIF-8 particles containing therapeutic genes for cancer immune therapy. Acta Pharm Sinica B. 2024;14:5418–34.
Zhang Y, Wang F, Ju E, Liu Z, Chen Z, Ren J, Qu X. Metal-organic-framework-based vaccine platforms for enhanced systemic immune and memory response. Adv Funct Mater. 2016;26:6454–61.
Rosenblum D, Joshi N, Tao W, Karp JM, Peer D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun. 2018;9:1410.
Ha L, Choi KM, Kim D-P. Interwoven MOF-coated Janus cells as a novel carrier of toxic proteins. ACS Appl Mater Interfaces. 2021;13:18545–53.
Yao J, Liu Y, Wang J, Jiang Q, She D, Guo H, Sun N, Pang Z, Deng C, Yang W, Shen S. On-demand CO release for amplification of chemotherapy by MOF functionalized magnetic carbon nanoparticles with NIR irradiation. Biomaterials. 2019;195:51–62.
Du L, He H, Xiao Z, Xiao H, An Y, Zhong H, Lin M, Meng X, Han S, Shuai X. GSH-responsive metal-organic framework for intratumoral release of NO and IDO inhibitor to enhance antitumor immunotherapy. Small 2022;18:2107732.
Yan X, Jing P, Zhuang Z, Zhang J, Chen H, Xia T, Jiang K. Co-delivery of vitamin and amino acid within MOFs for oxidative stress-based tumor gas therapy. J Colloid Interface Sci. 2025;680:518–28.
Zheng P, Ding B, Shi R, Jiang Z, Xu W, Li G, Ding J, Chen X. A multichannel Ca2+ nanomodulator for multilevel mitochondrial destruction-mediated cancer therapy. Adv Mater. 2021;33:2007426.
Zhang C, Bu W, Ni D, Zhang S, Li Q, Yao Z, Zhang J, Yao H, Wang Z, Shi J. Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized Fenton reaction. Angewandte Chemie-International Ed. 2016;55:2101–6.
Zhuang S, Xiang H, Chen Y, Wang L, Chen Y, Zhang J. Engineering 2D Cu-composed metal-organic framework nanosheets for augmented nanocatalytic tumor therapy. J Nanobiotechnol. 2022;20:66.
Yao M, Ma L, Li L, Zhang J, Lim RX, Chen W, Zhang Y. A new modality for cancer treatment-nanoparticle mediated microwave induced photodynamic therapy. J Biomed Nanotechnol. 2016;12:1835–51.
Ma Y, Su Z, Zhou L, He L, Hou Z, Zou J, Cai Y, Chang D, Xie J, Zhu C et al. Biodegradable metal-organic-framework-gated organosilica for tumor-microenvironment-unlocked glutathione-depletion-enhanced synergistic therapy. Adv Mater. 2022;34:2107560.
Ji P, Wang L, Wang S, Zhang Y, Qi X, Tao J, Wu Z. Hyaluronic acid-coated metal-organic frameworks benefit the ROS-mediated apoptosis and amplified anticancer activity of Artesunate. J Drug Target. 2020;28:1096–109.
Li H, Zhang Y, Liang L, Song J, Wei Z, Yang S, Ma Y, Chen WR, Lu C, Wen L. Doxorubicin-loaded metal-organic framework nanoparticles as acid-activatable hydroxyl radical nanogenerators for enhanced chemo/chemodynamic synergistic therapy. Materials 2022;15:1096.
Sun L, Xu Y, Gao Y, Huang X, Feng S, Chen J, Wang X, Guo L, Li M, Meng X et al. Synergistic amplification of oxidative stress-mediated antitumor activity via liposomal dichloroaceticacid and MOF-Fe2+. Small 2019;15:1901156.
Cui R, Shi J, Liu Z. Metal-organic framework-encapsulated nanoparticles for synergetic chemo/chemodynamic therapy with targeted H2O2 self-supply. Dalton Trans. 2021;50:15870–7.
Yang B, Ding L, Yao H, Chen Y, Shi J. A metal-organic framework (MOF) fenton nanoagent-enabled nanocatalytic cancer therapy in synergy with autophagy inhibition. Adv Mater. 2020;32:1907152.
Tu Y. Artemisinin-A gift from traditional Chinese medicine to the world (Nobel Lecture). Angewandte Chemie-International Ed. 2016;55:10210–26.
Yalamandala BN, Chen P-H, Moorthy T, Thi My Hue H, Chiang W-H, Hu S-H. Programmed catalytic therapy-mediated ROS generation and T-cell infiltration in lung metastasis by a dual metal-organic framework (MOF) nanoagent. Pharmaceutics 2022;14:527.
Xue T, Xu C, Wang Y, Wang Y, Tian H, Zhang Y. Doxorubicin-loaded nanoscale metal-organic framework for tumor-targeting combined chemotherapy and chemodynamic therapy. Biomaterials Sci. 2019;7:4615–23.
Gong Y, Leng J, Guo Z, Ji P, Qi X, Meng Y, Song X-Z, Tan Z. Cobalt dDoped in Zn-MOF-5 nanoparticles to regulate tumor microenvironment for tumor chemo/chemodynamic therapy. Chemistry-an Asian J. 2022;17:e202200392.
Wang F, Huang J, Xin H, Lei J. Triple-layered metal-organic framework hybrid for tandem response-driven enhanced chemotherapy. Chemistry-an Asian J. 2021;16:2068–74.
Zhao L, Li Z, Wei J, Xiao Y, She Y, Su Q, Zhao T, Li J, Shao J. Juglone-loaded metal-organic frameworks for H2O2 self-modulating enhancing chemodynamic therapy against prostate cancer. Chem Eng J. 2022;430:133057.
Hou L, Liu Y, Liu W, Balash M, Zhang H, Zhang Y, Zhang H, Zhang Z. In situ triggering antitumor efficacy of alcohol-abuse drug Disulfiram through Cu-based metal-organic framework nanoparticles. Acta Pharm Sinica B. 2021;11:2016–30.
Tang H, Zhou J, Yang T, Lyu H-N, Chu Z, Zhang Y, Ma A, Zhang J, Meng Y, Qiu C et al. Understanding the biological identity of metal-organic framework through profiling proteomic fingerprinting of protein corona. Chem Eng J. 2025;509:161320.
Ranji-Burachaloo H, Reyhani A, Gurr PA, Dunstan DE, Qiao GG. Combined Fenton and starvation therapies using hemoglobin and glucose oxidase. Nanoscale. 2019;11:5705–16.
Zhao H, Li T, Yao C, Gu Z, Liu C, Li J, Yang D. Dual roles of metal-organic frameworks as nanocarriers for MiRNA delivery and adjuvants for chemodynamic therapy. ACS Appl Mater Interfaces. 2021;13:6034–42.
Wu S, Zhang K, Liang Y, Wei Y, An J, Wang Y, Yang J, Zhang H, Zhang Z, Liu J, Shi J. Nano-enabled tumor systematic energy exhaustion via Zinc (II) interference mediated glycolysis inhibition and specific GLUT1 depletion. Adv Sci. 2022;9:2270045.
Wang P, Xiao M, Pei H, Xing H, Luo S-H, Tsung C-K, Li L. Biomineralized DNA nanospheres by metal organic framework for enhanced chemodynamic therapy. Chem Eng J. 2021;415:129036.
Wang J-W, Chen Q-W, Luo G-F, Han Z-Y, Song W-F, Yang J, Chen W-H, Zhang X-Z. A self-driven bioreactor based on bacterium-metal-organic framework biohybrids for boosting chemotherapy via lactate catabolism. ACS Nano. 2021;15:17870–84.
Wang Z, Niu J, Zhao C, Wang X, Ren J, Qu X. A bimetallic metal-organic framework encapsulated with DNAzyme for intracellular drug synthesis and self-sufficient gene therapy. Angewandte Chemie-International Ed. 2021;60:12431–7.
Hao Y-N, Qu C-C, Shu Y, Wang J-H, Chen W. Construction of novel nanocomposites (Cu-MOF/GOD@HA) for chemodynamic therapy. Nanomaterials 2021;11:1843.
Wan X, Song L, Pan W, Zhong H, Li N, Tang B. Tumor-targeted cascade nanoreactor based on metal-organic frameworks for synergistic ferroptosis-starvation anticancer therapy. ACS Nano. 2020;14:11017–28.
Pan Q, Xie L, Liu R, Pu Y, Wu D, Gao W, Luo K, He B. Two birds with one stone: Copper metal-organic framework as a carrier of disulfiram prodrug for cancer therapy. Int J Pharm. 2022;612:121351.
Liu P, Liu X, Cheng Y, Zhong S, Shi X, Wang S, Liu M, Ding J, Zhou W. Core-shell nanosystems for self-activated drug-gene combinations against triple-negative breast cancer. ACS Appl Mater Interfaces. 2020;12:53654–64.
Zhou J, Wang K, Ding S, Zeng L, Miao J, Cao Y, Zhang X, Tian G, Bian X-W. Anti-VEGFR2-labeled enzyme-immobilized metal-organic frameworks for tumor vasculature targeted catalytic therapy. Acta Biomater. 2022;141:364–73.
Ma W, Zhang H, Li S, Wang Z, Wu X, Yan R, Geng F, Mu W, Jin Y. A multifunctional nanoplatform based on fenton-like and Russell reactions of cu, Mn bimetallic ions synergistically enhanced ROS stress for improved chemodynamic therapy. Acs Biomaterials Sci Eng. 2022;8:1354–66.
He Z, Huang X, Wang C, Li X, Liu Y, Zhou Z, Wang S, Zhang F, Wang Z, Jacobson O, et al. A catalase-like metal-organic framework nanohybrid for O2-evolving synergistic chemoradiotherapy. Angewandte Chemie-International Ed. 2019;58:8752–6.
Yao D, Wang Y, Dong X, Chen Y, Ji D-K, Zou R, Huang Y, Huang W, Wang D. Renal-clearable and tumor-retained nanodots overcoming metabolic reprogramming to boost mitochondrial-targeted photodynamic therapy in triple-negative breast cancer. J Nanobiotechnol. 2025;23:195.
Liu J, Huang M, Hua Z, Ni J, Dong Y, Feng Z, Sun T, Chen C. Synergistic combination: Promising nanoplatform W-POM NCs@ HKUST-1 for photothermal and chemodynamic reinforced anti-tumor therapy. Appl Organomet Chem. 2022;36:e6693.
Cheng Y, Wen C, Sun Y-Q, Yu H, Yin X-B. Mixed-metal MOF-derived hollow porous nanocomposite for trimodality imaging guided reactive oxygen species-Augmented synergistic therapy. Adv Funct Mater. 2021;31:2104378.
Wang Z, Yu W, Yu N, Li X, Feng Y, Geng P, Wen M, Li M, Zhang H, Chen Z. Construction of CuS@Fe-MOF nanoplatforms for MRI-guided synergistic photothermal-chemo therapy of tumors. Chem Eng J. 2020;400:125877.
Cheng X, Liu Y, Zhou H, Leng J, Dai X, Wang D, Ma K, Cui C, Fu J, Guo Z. Cantharidin-loaded biomimetic MOF nanoparticle cascade to enhance the Fenton reaction based on amplified photothermal therapy. Biomaterials Sci. 2021;9:7862–75.
Zhang B, Shao C-w, Zhou K-M, Li Q, Duan Y-T, Yang Y-S, Zhu H-L. A NIR-triggered multifunctional nanoplatform mediated by Hsp70 SiRNA for chemo-hypothermal photothermal synergistic therapy. Biomaterials Sci. 2021;9:6501–9.
Wan X, Zhong H, Pan W, Li Y, Chen Y, Li N, Tang B. Programmed release of Dihydroartemisinin for synergistic cancer therapy using CaCO3 mineralized metal-organic framework. Angewandte Chemie-International Ed. 2019;58:14134–9.
Zhao Y, Wang J, Cai X, Ding P, Lv H, Pei R. Metal-organic frameworks with enhanced photodynamic therapy: synthesis, erythrocyte membrane camouflage, and aptamer-targeted aggregation. ACS Appl Mater Interfaces. 2020;12:23697–706.
Sheng S, Liu F, Lin L, Yan N, Wang Y, Xu C, Tian H, Chen X. Nanozyme-mediated cascade reaction based on metal-organic framework for synergetic chemo-photodynamic tumor therapy. J Controlled Release. 2020;328:631–9.
Cai Z, Xin F, Wei Z, Wu M, Lin X, Du X, Chen G, Zhang D, Zhang Z, Liu X, Yao C. Photodynamic therapy combined with antihypoxic signaling and CpG adjuvant as an in situ tumor vaccine based on metal-organic framework nanoparticles to boost cancer immunotherapy. Adv Healthc Mater. 2020;9:1900996.
Chen D, Suo M, Guo J, Tang W, Jiang W, Liu Y, Duo Y. Development of MOF armor-plated phycocyanin and synergistic inhibition of cellular respiration for hypoxic photodynamic therapy in patient-derived xenograft models. Adv Healthc Mater. 2021;10:2001577.
Chen Z-X, Liu M-D, Zhang M-K, Wang S-B, Xu L, Li C-X, Gao F, Xie B-R, Zhong Z-L, Zhang X-Z. Interfering with lactate-fueled respiration for enhanced photodynamic tumor therapy by a porphyrinic MOF nanoplatform. Adv Funct Mater. 2018;28:1803498.
Shi Z, Meng X, Zhang K, Tang S, Zhang C, Yang Z, Dong H, Zhang X. Engineering structural metal-organic framework for hypoxia-tolerant type I photodynamic therapy against hypoxic cancer. Acs Mater Lett. 2021;3:781–9.
Zou M, Zhao Y, Ding B, Jiang F, Chen Y, Ma Pa, Lin J. NIR-triggered biodegradable MOF-coated upconversion nanoparticles for synergetic chemodynamic/photodynamic therapy with enhanced efficacy. Inorg Chem Front. 2021;8:2624–33.
Wang Y, Wu W, Liu J, Manghnani PN, Hu F, Ma D, Teh C, Wang B, Liu B. Cancer-cell-activated photodynamic therapy assisted by Cu(II)-based metal-organic framework. ACS Nano. 2019;13:6879–90.
Zhang J, Li X, Han X, Liu R, Fang J. Targeting the thioredoxin system for cancer therapy. Trends Pharmacol Sci. 2017;38:794–808.
Cheng Q, Yu W, Ye J, Liu M, Liu W, Zhang C, Zhang C, Feng J, Zhang X-Z. Nanotherapeutics interfere with cellular redox homeostasis for highly improved photodynamic therapy. Biomaterials. 2019;224:119500.
Zhang L, Gao Y, Sun S, Li Z, Wu A, Zeng L. pH-Responsive metal-organic framework encapsulated gold nanoclusters with modulated release to enhance photodynamic therapy/chemotherapy in breast cancer. J Mater Chem B. 2020;8:1739–47.
Wang X, Wang Z, Ma W, Wu X, Fang W, Guo C, Jin Y. Construction of a nanotheranostic system Zr-MOF@PPa/AF@PEG for improved photodynamic therapy effects based on the PDT-oxygen consumption and hypoxia sensitive chemotherapeutic drug. J Photochem Photobiology B-Biology. 2021;222:112274.
Shao Y, Liu B, Di Z, Zhang G, Sun L-D, Li L, Yan C-H. Engineering of upconverted metal-organic frameworks for near-infrared light-triggered combinational photodynamic/chemo-/immunotherapy against hypoxic tumors. J Am Chem Soc. 2020;142:3939–46.
Liu P, Zhou Y, Shi X, Yuan Y, Peng Y, Hua S, Luo Q, Ding J, Li Y, Zhou W. A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances. J Nanobiotechnol. 2021;19:149.
Wang Y, Wu W, Mao D, Teh C, Wang B, Liu B. Metal-organic framework assisted and tumor microenvironment modulated synergistic image-guided photo-chemo therapy. Adv Funct Mater. 2020;30:2002431.
Cai X, Xie Z, Ding B, Shao S, Liang S, Pang M, Lin J. Monodispersed copper(I)-based nano metal-organic framework as a biodegradable drug carrier with enhanced photodynamic therapy efficacy. Adv Sci. 2019;6:1900848.
Song G, Liang C, Gong H, Li M, Zheng X, Cheng L, Yang K, Jiang X, Liu Z. Core-shell MnSe@Bi2Se3 fabricated via a cation exchange method as novel nanotheranostics for multimodal imaging and synergistic thermoradiotherapy. Adv Mater. 2015;27:6110–7.
Zhou Z, Zhao J, Di Z, Liu B, Li Z, Wu X, Li L. Core-shell gold nanorod@mesoporous-MOF heterostructures for combinational phototherapy. Nanoscale. 2021;13:131–7.
Li B, Wang X, Chen L, Zhou Y, Dang W, Chang J, Wu C. Ultrathin Cu-TCPP MOF nanosheets: a new theragnostic nanoplatform with magnetic resonance/near-infrared thermal imaging for synergistic phototherapy of cancers. Theranostics. 2018;8:4086–96.
Zhang K, Meng X, Cao Y, Yang Z, Dong H, Zhang Y, Lu H, Shi Z, Zhang X. Metal-organic framework nanoshuttle for synergistic photodynamic and low-temperature photothermal therapy. Adv Funct Mater. 2018;28:1804634.
Zou H, Li M, Li X, Zheng W, Kuang H, Wang M, Zhang W, Ran H, Ma H, Zhou X. Multimodal imaging and photothermal synergistic immunotherapy of retinoblastoma with tuftsin-loaded carbonized MOF nanoparticles. Drug Delivery. 2022;29:1785–99.
Zhang H, Zhang J, Li Q, Song A, Tian H, Wang J, Li Z, Luan Y. Site-specific MOF-based immunotherapeutic nanoplatforms via synergistic tumor cells-targeted treatment and dendritic cells-targeted immunomodulation. Biomaterials. 2020;245:119983.
Zeng J-Y, Zou M-Z, Zhang M, Wang X-S, Zeng X, Cong H, Zhang. X-Z: π-extended benzoporphyrin-based metal-organic framework for Inhibition of tumor metastasis. ACS Nano. 2018;12:4630–40.
Zhao X, Li Y, Du L, Deng Z, Jiang M, Zeng S. Soft X-ray stimulated lanthanide@MOF nanoprobe for amplifying deep tissue synergistic photodynamic and antitumor immunotherapy. Adv Healthc Mater. 2021;10:2101174.
Cao J, Sun Y, Zhang C, Wang X, Zeng Y, Zhang T, Huang P. Tablet-like TiO2/C nanocomposites for repeated type I sonodynamic therapy of pancreatic cancer. Acta Biomater. 2021;129:269–79.
Deng X, Guo Y, Zhang X, Wu W, Wu Y, Jing D, Wang D, Shao Z, Zhao Y. Film-facilitated formation of ferrocenecarboxylic acid-embedded metal-organic framework nanoparticles for sonodynamic osteosarcoma treatment. Mater Today Chem. 2022;24:100842.
Hu T, Wang T, Yang Y, Yu C, Yu J, Liang R, Ji W. 2D MOFs nanosheets derived from 2D LDHs as a multifunctional sensitizer for sono-photodynamic therapy-mediated tumor treatment. Chem Eng J. 2025;505:159771.
Ren Q, Yu N, Wang L, Wen M, Geng P, Jiang Q, Li M, Chen Z. Nanoarchitectonics with metal-organic frameworks and platinum nanozymes with improved oxygen evolution for enhanced sonodynamic/chemo-therapy. J Colloid Interface Sci. 2022;614:147–59.
Luo J, Wang X, Shi Z, Zeng Y, He L, Cao J, Sun Y, Zhang T, Huang P. Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy. J Nanobiotechnol. 2022;20:228.
Duan W, Li B, Zhang W, Li J, Yao X, Tian Y, Zheng J, Li D. Two-photon responsive porphyrinic metal-organic framework involving Fenton-like reaction for enhanced photodynamic and sonodynamic therapy. J Nanobiotechnol. 2022;20:217.
Sun Y, Cao J, Wang X, Zhang C, Luo J, Zeng Y, Zhang C, Li Q, Zhang Y, Xu W, et al. Hypoxia-adapted sono-chemodynamic treatment of orthotopic pancreatic carcinoma using copper metal-organic frameworks loaded with an ultrasound-induced free radical initiator. ACS Appl Mater Interfaces. 2021;13:38114–26.
Han X, Zhao C, Wang S, Pan Z, Jiang Z, Tang X. Multifunctional TiO2/C nanosheets derived from 3D metal-organic frameworks for mild-temperature-photothermal-sonodynamic-chemodynamic therapy under photoacoustic image guidance. J Colloid Interface Sci. 2022;621:360–73.
Dong Z, Feng L, Hao Y, Li Q, Chen M, Yang Z, Zhao H, Liu Z. Synthesis of CaCO3-based nanomedicine for enhanced sonodynamic therapy via amplification of tumor oxidative stress. Chem. 2020;6:1391–407.
Pu Y, Yin H, Dong C, Xiang H, Wu W, Zhou B, Du D, Chen Y, Xu H. Sono-controllable and ROS-sensitive CRISPR-Cas9 genome editing for augmented/synergistic ultrasound tumor nanotherapy. Adv Mater. 2021;33:2104641.
Liang S, Deng X, Ma Pa, Cheng Z, Lin J. Recent advances in nanomaterial-assisted combinational sonodynamic cancer therapy. Adv Mater. 2020;32:2003214
Zhan G, Xu Q, Zhang Z, Wei Z, Yong T, Bie N, Zhang X, Li X, Li J, Gan L, Yang X. Biomimetic sonodynamic therapy-nanovaccine integration platform potentiates Anti-PD-1 therapy in hypoxic tumors. Nano Today. 2021;38:101195.
Feng L, Cheng L, Dong Z, Tao D, Barnhart TE, Cai W, Chen M, Liu Z. Theranostic liposomes with hypoxiaactivated prodrug to effectively destruct hypoxic tumors post-photodynamic therapy. ACS Nano. 2017;11:927–37.
Du C, Zhou M, Jia F, Ruan L, Lu H, Zhang J, Zhu B, Liu X, Chen J, Chai Z, Hu Y. D-arginine-loaded metal-organic frameworks nanoparticles sensitize osteosarcoma to radiotherapy. Biomaterials. 2021;269:120642.
DuRoss AN, Landry MR, Thomas CR Jr., Neufeld MJ, Sun C. Preclinical data on co-delivery of Temozolomide and Talazoparib by fucodain-coated nanoscale metal organic frameworks for colorectal cancer chemoradiation. Data Brief. 2021;38:107394–107394.
Chen Y, Zhong H, Wang J, Wan X, Li Y, Pan W, Li N, Tang B. Catalase-like metal-organic framework nanoparticles to enhance radiotherapy in hypoxic cancer and prevent cancer recurrence. Chem Sci. 2019;10:5773–8.
Bao J, Zu X, Wang X, Li J, Fan D, Shi Y, Xia Q, Cheng J. Multifunctional Hf/Mn-TCPP metal-organic framework nanoparticles for triple-modality imaging-guided PTT/RT synergistic cancer therapy. Int J Nanomed. 2020;15:7687–702.
Li Q, Wu Z, Chen S, Liang Y, Zhu K, Su N, Liu T, Zhao B. Enhancing ferroptosis-mediated radiosensitization via synergistic Disulfidptosis induction. ACS Nano. 2024;19:1757–70.
Li S, Chen Z, Tan L, Wu Q, Ren X, Fu C, Niu M, Li H, Meng X. MOF@COF nanocapsule for the enhanced microwave thermal-dynamic therapy and anti-angiogenesis of colorectal cancer. Biomaterials. 2022;283:121472.
Izzo F, Granata V, Grassi R, Fusco R, Palaia R, Delrio P, Carrafiello G, Azoulay D, Petrillo A, Curley SA. Radiofrequency ablation and microwave ablation in liver tumors: an update. Oncologist. 2019;24:E990–1005.
Wu Q, Du Q, Sun X, Niu M, Tan L, Fu C, Ren X, Zheng Y, Liang T, Zhao J et al. MnMOF-based microwave-glutathione dual-responsive nano-missile for enhanced microwave Thermo-dynamic chemotherapy of drug-resistant tumors. Chem Eng J. 2022;439:135582.
Zhao L, Zhang W, Wu Q, Fu C, Ren X, Lv K, Ma T, Chen X, Tan L, Meng X. Lanthanide europium MOF nanocomposite as the theranostic nanoplatform for microwave thermo-chemotherapy and fluorescence imaging. J Nanobiotechnol. 2022;20:133.
